Interpace Biosciences/ US46062X3035 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
08-01
Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
GlobeNewswire
07-29
Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecula...
GlobeNewswire
06-04
Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Panc...
GlobeNewswire
05-09
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
GlobeNewswire
03-07
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business...
GlobeNewswire
2023-11-08
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
GlobeNewswire
2022-01-29
Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of i...
GlobeNewswire
2022-01-27
Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New Director
GlobeNewswire
2022-01-12
Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights Offering
GlobeNewswire
2022-01-03
Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights Offer...
GlobeNewswire
2021-11-10
Interpace Biosciences Announces Third Quarter 2021 Financial and Business Results
GlobeNewswire
2021-11-02
Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repaymen...
GlobeNewswire
2021-10-28
Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genot...
GlobeNewswire
2021-10-21
Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled:...
GlobeNewswire
2021-10-15
Interpace Biosciences Announces New $7.5 Million Credit Facility with Comerica Bank
GlobeNewswire
2021-08-10
Interpace Biosciences Announces Second Quarter 2021 Financial and Business Results
GlobeNewswire
2021-05-17
Interpace Pharma Solutions Announces New Capability in Spatial Biology/Precision Oncology Services
GlobeNewswire
2021-05-11
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
GlobeNewswire
2021-05-03
Interpace Biosciences Announces Improved Coverage for ThyGeNEXT® and ThyraMIR®
GlobeNewswire
2021-04-23
Delisting of Securities of Interpace Biosciences, Inc., Francesca's Holdings Corporation, and Wins F...
GlobeNewswire
2021-04-22
Interpace Biosciences to Explore Strategic Alternatives for Maximizing Shareholder Value
GlobeNewswire
2021-04-12
Interpace Pharma Solutions Announces New Advanced Offering in RNA Biomarker Analysis
GlobeNewswire
2021-04-05
Interpace Biosciences Announces New PLA Code and Medicare Reimbursement Increase for Proprietary Thy...
GlobeNewswire
2021-03-31
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results